Canbin Lin
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 7
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 7
- Co-authors
- Xiang Pan (11 shared papers)Yongqing Lai (13 shared papers)Jing Quan (11 shared papers)Peijie Chen (8 shared papers)Shangqi Yang (9 shared papers)Tao He (5 shared papers)Yulin Lai (6 shared papers)Liwen Zhao (8 shared papers)
- Journals
- Medicine (2 papers)Biomedicine & Pharmacotherapy (2 papers)Life Sciences (2 papers)Journal of Orthopaedic Surgery and Research (1 paper)Brazilian Journal of Medical and Biological Research (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Canbin Lin
19 papers receiving 305 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 178
- Molecular Biology 191
- Pulmonary and Respiratory Medicine 31
- Nephrology 5
- Immunology 15
Countries citing papers authored by Canbin Lin
This map shows the geographic impact of Canbin Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Canbin Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Canbin Lin more than expected).
Fields of papers citing papers by Canbin Lin
This network shows the impact of papers produced by Canbin Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Canbin Lin. The network helps show where Canbin Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Canbin Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 66 | |
| 2 | 2018 | 34 | |
| 3 | 2018 | 31 | |
| 4 | 2018 | 24 | |
| 5 | 2018 | 22 | |
| 6 | 2017 | 21 | |
| 7 | 2017 | 20 | |
| 8 | 2018 | 16 | |
| 9 | 2018 | 16 | |
| 10 | miR-625-3p promotes migration and invasion and reduces apoptosis of clear cell renal cell carcinoma. | 2019 | 14 |
| 11 | 2018 | 11 | |
| 12 | 2020 | 10 | |
| 13 | Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC. | 2020 | 8 |
| 14 | 2017 | 7 | |
| 15 | 2017 | 4 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 1 | |
| 18 | 2023 | 1 | |
| 19 | 2018 | 1 | |
| 20 | 2025 | 0 |
About Canbin Lin
Canbin Lin is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 23 papers that have together received 310 indexed citations. Recurring topics across this work include Circular RNAs in diseases (7 papers), MicroRNA in disease regulation (7 papers), Cancer-related molecular mechanisms research (7 papers), Renal cell carcinoma treatment (2 papers), Tuberous Sclerosis Complex Research (2 papers), Ferroptosis and cancer prognosis (1 paper), Image Enhancement Techniques (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (178 citations), Molecular Biology (191 citations), Pulmonary and Respiratory Medicine (31 citations), Nephrology (5 citations) and Immunology (15 citations). Canbin Lin has collaborated with scholars based in China and United States. Frequent co-authors include Xiang Pan, Yongqing Lai, Jing Quan, Peijie Chen, Shangqi Yang, Tao He, Yulin Lai, Liwen Zhao, Jinling Xu and Xin Guan. Their work appears in journals such as Medicine, Biomedicine & Pharmacotherapy, Life Sciences, Journal of Orthopaedic Surgery and Research and Brazilian Journal of Medical and Biological Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.